Komori
Kaken Pharmaceutical (4521) · InitiativeAdvanced

Promoting environmental conservation and operating ISO 14001

First written in FY2017. 2 of 4 entries say "Restated". Latest entry: FY2026.

4entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20192017: 120172018: 120182019: 120192020: 020202021: 020212022: 020222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
Continuation of ISO 14001 Environmental Management CertificationA theme 51 companies write about · 0 as a headwind · 52 as a tailwind

12 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「We are working to reduce CO2 emissions to achieve the target set by the Group of reducing fiscal 2030 CO2 emissions by 51% from fiscal 2016 levels. Going forward, we aim to gradually increase the proportion of CO2-free electricity to 80% by fiscal 2030.」

    The environmental conservation policy has been translated into specific numerical targets of a 51% reduction in CO2 emissions by fiscal 2030 and an 80% share of CO2-free electricity, together with measures including high-efficiency equipment, LED lighting, CO2-free electricity, and internal carbon pricing.
  2. FY2019RestatedAnnual report

    「Recognising environmental conservation as a corporate social responsibility, the company is addressing it across the organisation, led by the Environmental Committee, and its Shizuoka facility has obtained ISO 14001 certification.」

    The company continues its organisation-wide environmental conservation initiatives led by the Environmental Committee and the operation of ISO 14001 certification at its Shizuoka facility.
  3. FY2018RestatedAnnual report

    「Recognising environmental conservation as a corporate social responsibility, the company is addressing it across the organisation, led by the Environmental Committee, and its Shizuoka facility has obtained ISO 14001 certification.」

    The company continues to report organisation-wide environmental conservation initiatives led by the Environmental Committee and the Shizuoka facility's ISO 14001 certification.
  4. FY2017First statedAnnual report

    「Recognising environmental conservation as a corporate social responsibility, the company is addressing it across the organisation, led by the Environmental Committee, and its Shizuoka facility has obtained ISO 14001 certification.」

    The company describes its organisation-wide environmental conservation initiatives led by the Environmental Committee and the Shizuoka facility's ISO 14001 certification.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kaken Pharmaceutical's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.